Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20033805HPVENSG00000078142.14protein_codingPIK3C3NoNo5289A8MYT4
Q8NEB9
TVIS44007240HTLV-1ENSG00000078142.14protein_codingPIK3C3NoNo5289A8MYT4
Q8NEB9
TVIS44005245HTLV-1ENSG00000078142.14protein_codingPIK3C3NoNo5289A8MYT4
Q8NEB9
TVIS44042418HTLV-1ENSG00000078142.14protein_codingPIK3C3NoNo5289A8MYT4
Q8NEB9
TVIS44042469HTLV-1ENSG00000078142.14protein_codingPIK3C3NoNo5289A8MYT4
Q8NEB9
TCGA Plot Options
Drug Information
GenePIK3C3
DrugBank IDDB11962
Drug NameGSK-1059615
Target IDBE0003729
UniProt IDQ8NEB9
Regulation Typeinhibitor
PubMed IDs32610557
CitationsYang CY, Liu CR, Chang IY, OuYang CN, Hsieh CH, Huang YL, Wang CI, Jan FW, Wang WL, Tsai TL, Liu H, Tseng CP, Chang YS, Wu CC, Chang KP: Cotargeting CHK1 and PI3K Synergistically Suppresses Tumor Growth of Oral Cavity Squamous Cell Carcinoma in Patient-Derived Xenografts. Cancers (Basel). 2020 Jun 29;12(7). pii: cancers12071726. doi: 10.3390/cancers12071726.
GroupsInvestigational
Direct ClassificationBipyridines and oligopyridines
SMILESO=C1NC(=O)C(S1)=CC1=CC=C2N=CC=C(C3=CC=NC=C3)C2=C1
Pathways
PharmGKB
ChEMBLCHEMBL3544966